Comparing to free anti-CTLA-4 antibody + Doxil, CTLA-4 PEG-liposomes (modification of liposomes by covalent conjugation with PEG) + Doxil showed even better tumor inhibition and survival rate. The gene discussed is CTLA4; the disease is neoplasm.